Cargando…
Dipeptidyl peptidase-4 inhibitor use and mortality in COVID-19 patients with diabetes mellitus: an updated systematic review and meta-analysis
BACKGROUND: Few observational studies have shown a beneficial effect of dipeptidyl peptidase-4 inhibitors (DPP4i) in patients with coronavirus disease 2019 (COVID-19), although results are not consistent. The present systematic review and meta-analysis was undertaken to provide a precise summary of...
Autores principales: | Pal, Rimesh, Banerjee, Mainak, Mukherjee, Soham, Bhogal, Ranjitpal Singh, Kaur, Amanpreet, Bhadada, Sanjay K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7897812/ https://www.ncbi.nlm.nih.gov/pubmed/33680425 http://dx.doi.org/10.1177/2042018821996482 |
Ejemplares similares
-
Cardiovascular efficacy and safety of dipeptidyl peptidase-4 inhibitors: A meta-analysis of cardiovascular outcome trials
por: Patoulias, Dimitrios Ioannis, et al.
Publicado: (2021) -
Cortisol concentrations and mortality from COVID-19
por: Pal, Rimesh, et al.
Publicado: (2020) -
Increased mortality for colorectal cancer patients with preexisting diabetes mellitus: an updated meta-analysis
por: Li, Jingtao, et al.
Publicado: (2017) -
Prevalence and Etiological Profile of Hypercalcemia in Hospitalized Adult Patients and Association with Mortality
por: Sulaiman, Shabna, et al.
Publicado: (2022) -
Diabetes mellitus and the risk of cholangiocarcinoma: an updated meta-analysis
por: Li, Junshan, et al.
Publicado: (2015)